CRIS Current Research Information System

FAVONI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.168
AS - Asia 1.916
EU - Europa 1.297
SA - Sud America 182
AF - Africa 93
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.144
SG - Singapore 642
VN - Vietnam 499
CN - Cina 356
GB - Regno Unito 264
IT - Italia 241
DE - Germania 204
HK - Hong Kong 201
SE - Svezia 159
BR - Brasile 137
NL - Olanda 93
IN - India 86
RU - Federazione Russa 67
FR - Francia 54
IE - Irlanda 52
JO - Giordania 39
FI - Finlandia 32
BG - Bulgaria 27
ZA - Sudafrica 27
NG - Nigeria 25
UA - Ucraina 21
AR - Argentina 20
PK - Pakistan 18
AT - Austria 17
KR - Corea 17
PL - Polonia 17
CI - Costa d'Avorio 16
EE - Estonia 13
CA - Canada 12
JP - Giappone 12
EC - Ecuador 10
ID - Indonesia 10
MX - Messico 10
TG - Togo 10
ES - Italia 8
BE - Belgio 7
PY - Paraguay 6
TH - Thailandia 6
BD - Bangladesh 4
LT - Lituania 4
UZ - Uzbekistan 4
CH - Svizzera 3
CO - Colombia 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
SC - Seychelles 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
IQ - Iraq 2
LB - Libano 2
MT - Malta 2
PE - Perù 2
QA - Qatar 2
RO - Romania 2
TN - Tunisia 2
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
LY - Libia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SN - Senegal 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.659
Salva come PNG Salva come JPEG
Città #
Singapore 408
Ashburn 258
Southend 227
Fairfield 213
Hong Kong 201
Santa Clara 167
Ho Chi Minh City 142
Woodbridge 122
Hanoi 121
Chandler 112
Houston 105
Seattle 94
Ann Arbor 91
Princeton 80
Wilmington 80
Cambridge 78
Beijing 66
Boardman 58
Dublin 52
Hefei 47
Amman 39
Turin 39
Bologna 34
Los Angeles 29
Sofia 27
Abeokuta 25
Redmond 25
Redondo Beach 24
Buffalo 23
Westminster 23
Dong Ket 22
San Diego 21
Berlin 20
Chengdu 20
Helsinki 19
Munich 19
Abidjan 16
Biên Hòa 15
Milan 15
Nanjing 15
Des Moines 14
Monzuno 14
Seoul 14
New York 13
Haiphong 12
São Paulo 11
Vũng Tàu 11
Warsaw 11
Da Nang 10
Lomé 10
Ninh Bình 10
Nuremberg 10
Quận Một 10
Saint Petersburg 10
Shenyang 10
Tokyo 10
Frankfurt am Main 9
Ha Long 9
Hebei 9
Jakarta 9
Nanchang 9
Padova 9
Phoenix 9
Shanghai 9
Covent Garden 8
Falkenstein 8
Guangzhou 8
Brussels 7
Chicago 7
Dallas 7
Dearborn 7
Jacksonville 7
Jiaxing 7
Jinan 7
Lappeenranta 7
Muzaffargarh 7
Redwood City 7
Vienna 7
Brasília 6
Hyderabad 6
Hải Dương 6
Olalla 6
Shenzhen 6
Tianjin 6
Turku 6
Atlanta 5
Bangkok 5
Belo Horizonte 5
Bengaluru 5
Brooklyn 5
Changsha 5
Gujranwala 5
Imola 5
Mexico City 5
Parma 5
Quận Bình Thạnh 5
Stockholm 5
Wroclaw 5
Yubileyny 5
Can Tho 4
Totale 3.661
Salva come PNG Salva come JPEG
Nome #
Central and Peripheral Nervous Disorders 205
Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache 175
Greater Occipital Nerve Infiltration During Pregnancy in Cluster Headache: A Case Report 168
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 167
Treatment of withdrawal headache in patients with medication overuse headache: a pilot study 164
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 160
Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. 157
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 154
Migraine and sleep disorders. 146
Vessel-wall MRI in primary headaches: The role of neurogenic inflammation 145
Migraine chronification as an allostatic disorder: a proof-of-concept study 141
Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series 137
The incidental finding of elevated anti GQ1B antibodies in a patient with selective small fiber neuropathy 132
Transverse Sinus Stenosis in Refractory Chronic Headache Patients: An Observational Study 132
Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording 128
CGRP and migraine from a cardiovascular point of view: What do we expect from blocking CGRP? 127
Superficial siderosis associated with peripheral autonomic failure and tetraventricular hydrocephalus: a case report 123
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 121
Recurrent Reversible Cognitive Impairment in a Cluster Headache Patient: A Case Report 121
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 119
Migraine and cardiovascular diseases. 118
Is physiotherapy in migraines known to sufferers? A cross-sectional study 117
SUNCT/SUNA and neurovascular compression: New cases and critical literature review. 117
Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network 116
Quality indicators in headache care: an implementation study in six Italian specialist-care centres 116
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache 115
Erenumab efficacy in highly resistant chronic migraine: a real-life study 112
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache 111
Nociception and autonomic nervous system. 110
State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study 109
Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center 107
Energy Metabolism Impairment in Migraine 104
Idiopathic intracranial hypertension without papilledema in refractory chronic daily headache 102
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study 98
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 97
Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network 90
Vessel-wall MRI in thunderclap headache: A useful tool to answer the riddle? 90
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 79
P063. Colloid cysts of the third ventricle: a case report 77
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 76
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 76
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 73
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 66
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 65
Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol 62
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance 59
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study 58
The ultimate guide to the anti-CGRP monoclonal antibodies galaxy 46
An unusual case of anti-basal ganglia encephalitis showing polyradiculoneuritis features 44
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 43
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 42
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 40
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 35
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 35
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 32
Moving closer to the ideal migraine acute treatment 19
Totale 5.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 11 14 29 60 25 18 85
2021/2022635 37 16 41 31 63 20 13 85 21 75 142 91
2022/2023681 64 69 23 81 67 43 38 38 144 29 65 20
2023/2024290 10 42 23 47 11 51 24 19 8 29 9 17
2024/20251.286 50 239 90 71 220 65 60 43 11 100 59 278
2025/20261.585 528 206 212 209 289 141 0 0 0 0 0 0
Totale 5.778